KRAS mutation and p53 loss of function are common characteristics of sporadic and CD related small bowel cancer, whereas p16 positivity, the nuclear accumulation of β-catenin and mutations of isocitrate dehydrogenase (IDH)-1 seem to be specific in CD small bowel cancer (122). Here, KRAS is linked to small intestine carcinoma.